Access the full text.
Sign up today, get DeepDyve free for 14 days.
D. Cutlip, S. Windecker, R. Mehran, A. Boam, D. Cohen, G. Es, P. Steg, M. Morel, L. Mauri, P. Vranckx, E. Mcfadden, A. Lansky, M. Hamon, M. Krucoff, P. Serruys (2007)
Clinical End Points in Coronary Stent Trials: A Case for Standardized DefinitionsCirculation, 115
G. Stone, S. Ellis, C. O'shaughnessy, Steven Martin, L. Satler, T. Mcgarry, M. Turco, D. Kereiakes, Lynne Kelley, J. Popma, M. Russell (2006)
Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial.JAMA, 295 11
G. Stone, S. Ellis, D. Cox, J. Hermiller, C. O'shaughnessy, J. Mann, M. Turco, R. Caputo, P. Bergin, Joel Greenberg, J. Popma, M. Russell (2004)
A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease.The New England journal of medicine, 350 3
J. Moses, M. Leon, J. Popma, P. Fitzgerald, D. Holmes, C. O'shaughnessy, R. Caputo, D. Kereiakes, David Williams, P. Teirstein, Judith Jaeger, R. Kuntz (2003)
Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery.The New England journal of medicine, 349 14
D. Holmes, P. Teirstein, L. Satler, M. Sketch, James O'Malley, J. Popma, R. Kuntz, P. Fitzgerald, Hong Wang, E. Caramanica, Sidney Cohen (2006)
Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial.JAMA, 295 11
R. Mehran, G. Dangas, Andrea Abizaid, G. Mintz, A. Lansky, L. Satler, A. Pichard, K. Kent, G. Stone, M. Leon (1999)
Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome.Circulation, 100 18
R. Sakurai, Y. Hongo, M. Yamasaki, Y. Honda, H. Bonneau, P. Yock, Donald Cutlip, J. Popma, P. Zimetbaum, J. Fajadet, R. Kuntz, W. Wijns, P. Fitzgerald (2007)
Detailed intravascular ultrasound analysis of Zotarolimus-eluting phosphorylcholine-coated cobalt-chromium alloy stent in de novo coronary lesions (results from the ENDEAVOR II trial).The American journal of cardiology, 100 5
G. Sarno, B. Lagerqvist, Ole Fröbert, J. Nilsson, G. Olivecrona, E. Omerovic, N. Saleh, Dimitris Venetzanos, S. James (2012)
Lower risk of stent thrombosis and restenosis with unrestricted use of 'new-generation' drug-eluting stents: a report from the nationwide Swedish Coronary Angiography and Angioplasty Registry (SCAAR).European heart journal, 33 5
L. Räber, Lea Wohlwend, M. Wigger, M. Togni, Simon Wandel, P. Wenaweser, S. Cook, Aris Moschovitis, R. Vogel, B. Kalesan, C. Seiler, F. Eberli, T. Lüscher, B. Meier, P. Jüni, S. Windecker (2011)
Five-Year Clinical and Angiographic Outcomes of a Randomized Comparison of Sirolimus-Eluting and Paclitaxel-Eluting Stents: Results of the Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization LATE TrialCirculation, 123
K. Waseda, J. Ako, M. Yamasaki, Tomomi Koizumi, J. Ormiston, S. Worthley, R. Whitbourn, D. Walters, Y. Honda, I. Meredith, P. Fitzgerald (2010)
Short- and mid-term intravascular ultrasound analysis of the new zotarolimus-eluting stent with durable polymer – results from the RESOLUTE trial –.Circulation journal : official journal of the Japanese Circulation Society, 74 10
Ki-Woon Kang, Y. Ko, D. Shin, Jung‐Sun Kim, Byeong‐Keuk Kim, D. Choi, Y. Jang, M. Hong (2012)
Comparison of Vascular Remodeling in Patients Treated With Sirolimus‐Versus Zotarolimus‐Eluting Stent Following Acute Myocardial InfarctionClinical Cardiology, 35
Haegeun Song, Duk‐Woo Park, Young-Hak Kim, Jung‐Min Ahn, Won-Jang Kim, Jong-Young Lee, Soo-Jin Kang, Seung‐Whan Lee, Cheol-Whan Lee, Seong-Wook Park, Seungbong Han, I. Seong, N. Lee, Bong-Ki Lee, K. Lee, Seung-Wook Lee, D. Nah, Seung‐Jung Park (2012)
Randomized trial of optimal treatment strategies for in-stent restenosis after drug-eluting stent implantation.Journal of the American College of Cardiology, 59 12
G. Stone, S. Ellis, L. Cannon, J. Mann, Joel Greenberg, D. Spriggs, C. O'shaughnessy, Samuel DeMaio, Patrick Hall, J. Popma, J. Koglin, Mary Russell (2005)
Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial.JAMA, 294 10
A. Kastrati, J. Mehilli, N. Beckerath, A. Dibra, J. Hausleiter, J. Pache, H. Schühlen, C. Schmitt, J. Dirschinger, A. Schömig (2005)
Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial.JAMA, 293 2
M. Degertekin, P. Lemos, Chi‐Hang Lee, K. Tanabe, J. Sousa, A. Abizaid, E. Regar, G. Sianos, W. Giessen, P. Feyter, E. Wuelfert, J. Popma, P. Serruys (2004)
Intravascular ultrasound evaluation after sirolimus eluting stent implantation for de novo and in-stent restenosis lesions.European heart journal, 25 1
S. Silber, S. Windecker, P. Vranckx, P. Serruys (2011)
Unrestricted randomised use of two new generation drug-eluting coronary stents: 2-year patient-related versus stent-related outcomes from the RESOLUTE All Comers trialThe Lancet, 377
Ki-Woon Kang, Y. Ko, D. Shin, Jung‐Sun Kim, Byeong‐Keuk Kim, D. Choi, M. Hong, W. Kang, T. Ahn, D. Jeon, Joo Yang, Y. Jang (2012)
Impact of positive peri-stent vascular remodeling after sirolimus-eluting and paclitaxel-eluting stent implantation on 5-year clinical outcomes: intravascular ultrasound analysis from the Poststent Optimal Stent Expansion Trial multicenter randomized trial.Circulation journal : official journal of the Japanese Circulation Society, 76 5
J. Forrester, M. Fishbein, R. Helfant, J. Fagin (1991)
A paradigm for restenosis based on cell biology: clues for the development of new preventive therapies.Journal of the American College of Cardiology, 17 3
L. Räber, M. Magro, G. Stefanini, B. Kalesan, R. Domburg, Y. Onuma, P. Wenaweser, J. Daemen, B. Meier, P. Jüni, P. Serruys, S. Windecker (2012)
Very Late Coronary Stent Thrombosis of a Newer-Generation Everolimus-Eluting Stent Compared With Early-Generation Drug-Eluting Stents: A Prospective Cohort StudyCirculation, 125
Objectives We aimed to evaluate the mid‐term outcomes of resolute zotarolimus‐eluting stent (R‐ZES) implantation for in‐stent restenosis (ISR). Background There has been a paucity of data regarding the effects of new‐generation drug‐eluting stent to treat ISR. Methods From 2009 to 2010, a total of 98 patients with 98 ISR lesions were prospectively enrolled after R‐ZES implantation for the treatment of ISR. Among 98 patients, 73 patients underwent follow‐up angiography at 9 months. Serial intravascular ultrasound (IVUS) at both postprocedure and 9 months was evaluated in 55 patients. The overlapped segment of R‐ZES was defined as the portion of R‐ZES superimposed on previous stent. Results Late loss and binary restenosis rate were 0.3 ± 0.5 mm and 5.5% at 9 months. On IVUS, the percentage of neointimal volume and maximum percentage of neointimal area were 3.9 ± 6.3% and 17.3 ± 15.5%, respectively. There was no significant change of vessel volume index between postprocedure and 9 months (16.9 ± 4.7 mm3/mm vs. 17.1 ± 4.6 mm3/mm, P = 0.251). Late‐acquired incomplete stent apposition was observed in 5 (5/55, 9.1%) cases. Compared with nonoverlapped segments of R‐ZES, the overlapped did not show larger neointimal volume index (0.3 ± 0.5 mm3/mm vs. 0.2 ± 0.3 mm3/mm, P = 0.187) on 9‐month IVUS. During follow‐up (median, 353 days), repeat target‐lesion revascularization was performed in four cases, but there were no death or stent thrombosis. Conclusions This study suggested that R‐ZES implantation for the treatment of ISR was effective up to 9 months and showed favorable vascular responses on serial IVUS assessment.
Journal of Interventional Cardiology – Wiley
Published: Dec 1, 2013
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.